Bromide

Bromide

SCHEMBL636852

CCCC[S+](CCCC)CCCC.[Br-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.43
LMNA P02545 2/20 0.43
THRB P10828 1/20 0.40
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
HIF1A Q16665 1/20 0.35
TDP1 Q9NUW8 1/20 0.33
DNM1 Q05193 7/20 0.32
SLC22A1 O15245 2/20 0.32
SLC22A2 O15244 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98416 0.96 TSHR (0.46) TSHRLMNATHRBALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL637380 0.92 TSHR (0.43) TSHRLMNATHRBALDH1A1SMN1; SMN2
Iodide SCHEMBL396287 0.92 TSHR (0.43) TSHRLMNATHRBALDH1A1SMN1; SMN2
Water SCHEMBL5664000 0.92 TSHR (0.43) TSHRLMNATHRBALDH1A1SMN1; SMN2
SCHEMBL12762111 0.92 TSHR (0.43) TSHRLMNATHRBALDH1A1SMN1; SMN2
SCHEMBL4238292 0.89 TSHR (0.47) TSHRLMNATHRBALDH1A1SMN1; SMN2
SCHEMBL3310909 0.89 TSHR (0.40) TSHRLMNATHRBALDH1A1SMN1; SMN2
Bromide SCHEMBL3256197 0.89 TSHR (0.47) TSHRLMNATHRBALDH1A1SMN1; SMN2
SCHEMBL3308158 0.89 TSHR (0.40) TSHRLMNATHRBALDH1A1SMN1; SMN2
Bromide SCHEMBL3839421 0.86 TSHR (0.38) TSHRLMNATHRBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4478751-A Complex salts having high electric conductivity BAYER AKTIENGESELLSCHAFT (DE) 1984-10-23 US claimed
US-12509632-B2 Treatment liquid for semiconductors and method for producing same TOKUYAMA CORPORATION (JP) 2025-12-30 US disclosed
CN-120060857-A Treatment liquid for ruthenium semiconductor and method for producing same 株式会社德山 2025-05-30 CN disclosed
US-12247299-B2 Treatment liquid for semiconductor with ruthenium and method of producing the same TOKUYAMA CORPORATION (JP) 2025-03-11 US disclosed
CN-114466951-B Treatment liquid for ruthenium semiconductor and method for producing same 株式会社德山 2025-02-28 CN disclosed
EP-4157910-B1 USE OF EPOXY COMPOUNDS AS CARBON DIOXIDE SCAVENGERS IN PIR COMPRISING FOAMS FOR SUPERIOR THERMAL INSULATION PROPERTIES HUNTSMAN INT LLC (US) 2025-02-26 EP disclosed
US-12195658-B2 Treatment liquid for semiconductor wafers TOKUYAMA CORPORATION (JP) 2025-01-14 US disclosed
WO-2024146848-A1 CURABLE MATERIALS BASED ON CYCLIC THIOETHER COMPOUNDS, AND USES THEREOF DELO INDUSTRIE KLEBSTOFFE GMBH & CO. KGAA (DE) 2024-07-11 WO disclosed
WO-2024063027-A1 CROSSLINKED RUBBER AND TIRE USING SAME 株式会社ブリヂストン 2024-03-28 WO disclosed
EP-4023791-B1 SEMICONDUCTOR TREATMENT LIQUID FOR RUTHENIUM AND METHOD FOR PRODUCING SAME TOKUYAMA CORP (JP) 2023-10-11 EP disclosed
EP-0936233-A2 Composition for a resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1999-08-18 EP disclosed
US-5786401-A CONCURRENT BLOWING, MOLDING OF POLYURETHANE MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1998-07-28 US disclosed
US-5741825-A CLOSED CELL FOAM FOR HEAT RESISTANCE FORMED BY BLOWING WITH IODOFLUOROHYDROCARBONS AND HYDROGEN CONTAINING FLUOROMORPHOLINE MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1998-04-21 US disclosed
EP-0700953-A2 Thermal insulating foamed material and method for manufacturing the same MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1996-03-13 EP disclosed
EP-0073379-B1 COMPLEX SALTS WITH INCREASED ELECTRICAL CONDUCTIVITY BAYER AG (DE) 1986-08-13 EP disclosed
US-4478751-A Complex salts having high electric conductivity BAYER AKTIENGESELLSCHAFT (DE) 1984-10-23 US disclosed
EP-0073379-A1 Complex salts with increased electrical conductivity BAYER AG (DE) 1983-03-09 EP disclosed
US-4260555-A CONDENSING A CYANOALKYL PHENYLSULFONATE WITH OXIMINOARYLNITRILE CIBA-GEIGY CORPORATION (US) 1981-04-07 US disclosed
US-4148814-A Process for preparing monohydrocarbyltin trihalides PENNWALT CORPORATION (US) 1979-04-10 US disclosed
US-4129584-A Process for preparing dimethyltin dichloride PENNWALT CORPORATION (US) 1978-12-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509632-B2 Treatment liquid for semiconductors and method for producing same GRIN2D, WIZ, EED TSHR 869/4885LMNA 3498/4885THRB 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.